Paolo Tarantino, Research Fellow at The Dana-Farber Cancer Institute, shared a post on X:
“Join us tomorrow for live discussion on the evolving role of ADCs across tumor histologies. Powered by OncoViews.
Link: oncoviews.com.”
More posts featuring Paolo Tarantino.
Dr. Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan. His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field.